Scientists at St. Jude Children's Research Hospital demonstrated for the first time that the protein midkine plays a ...

Headquartered in Chicago, the company’s mission is clear: to make early detection of Alzheimer’s and other neurodegenerative ...

A computer program predicts with more than 75% accuracy who will develop dementia in the near future. D.C. residents drive ...

Tau is associated with the amyloid beta plaques and tau tangles that riddle the brains of people with Alzheimer’s, ...

Daily sleep and activity are fundamental to both physical and mental health. Although previous studies have largely ...

Sleep apnea is drawing new attention from health experts who say it may play a bigger role in America’s chronic disease ...

Longer-term data show that donanemab’s cognitive benefits continue to grow over time, and earlier initiation reduces the risk for progression, with no new safety signals.

Supreme Court sides with Trump on cutting government grant programs involving diversity, equity and inclusion.

GLP-1 receptor agonists may outperform metformin in lowering the risk for dementia, particularly Alzheimer’s disease and other nonvascular types, in patients with type 2 diabetes.

Seniors experiencing memory problems and cognitive decline now have access to a new diagnostic blood test to detect Alzheimer’s disease. Labcorp this week unveiled the first Food and Drug ...

Medicare launched a new program called GUIDE (Guiding an Improved Dementia Experience) to support individuals diagnosed with dementia and their caregivers. The program offers a $2,563 respite care ...

Disease-modifying therapies are expected to account for 69.2% of the market. The Alzheimer’s disease (AD) market across the ...